Cardon Lon 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jun 14, 2023
Insider Transaction Report
Form 4
Cardon Lon
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-12+7,083→ 7,083 totalExercise: $28.97Exp: 2033-06-11→ Common Stock (7,083 underlying)
Footnotes (1)
- [F1]The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2024 annual stockholder meeting.